Diagnostic and pathogenetic significance of apolipoprotein disorders in patients with alcoholic fatty liver

Diagnostic and pathogenetic significance of apolipoprotein disorders in patients with alcoholic fatty liver

Background/Aim. Alcohol is the most common cause of fatty liver. Alcohol metabolism takes place in the liver by alcohol dehydrogenase, to toxic acetaldehyde, with fatty acids accumulation in the liver as a consequence. By daily intake of the amount greater than 80 g/day for men and 20 g for women, t...

Full description

Bibliographic Details
Main Authors:	Mladenović Bojan, Brzački Vesna, Benedeto-Stojanov Daniela, Mladenović Nikola
Format:	Article
Language:	English
Published:	Military Health Department, Ministry of Defance, Serbia 2017-01-01
Series:	Vojnosanitetski Pregled
Subjects:	liver disease, alcoholic non-alcoholic fatty liver disease risk factors apolipoproteins a apolipoproteins b lipids diagnosis alcohol drinking
Online Access:	http://www.doiserbia.nb.rs/img/doi/0042-8450/2017/0042-84501600170M.pdf

Similar Items

The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
by: Jong Hwa Choi, et al.
Published: (2020-10-01)

Impact of Apolipoprotein B on Hepatosteatosis in a Population Infected with Hepatitis C Virus: A Cross-Sectional Observational Study
by: Ming-Shyan Lin, et al.
Published: (2016-04-01)

Changes in indicators of fibrosis in patients with alcoholic liver cirrhosis associated with non-alcoholic fatty liver disease depending on the stage of cirrhosis
by: N. R. Matkovska, et al.
Published: (2020-06-01)

Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice
by: Nuria Ardaiz, et al.
Published: (2021-02-01)

Evaluation of comorbidity in patients with alcoholic cirrhosis of the liver associated with non-alcoholic fatty liver disease
by: N. R. Matkovska, et al.
Published: (2020-04-01)

Contemporary aspects of the diagnostics of alcoholic liver disease
by: Nikolić Jelenka, et al.
Published: (2012-01-01)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
by: Francesca Cainelli, et al.
Published: (2020-02-01)

Bilirubin Nanoparticles Reduce Diet-Induced Hepatic Steatosis, Improve Fat Utilization, and Increase Plasma β-Hydroxybutyrate
by: Terry D. Hinds, et al.
Published: (2020-12-01)

Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
by: Dongqing Wu, et al.
Published: (2021-07-01)

Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound
by: Petrović Gordana, et al.
Published: (2016-01-01)

Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?
by: Ju Hyun Shim
Published: (2020-04-01)

Clinical and Pathogenetic Parallels of Nonalcoholic Fatty Liver Disease and Gallstone Disease
by: Aleksey O. Bueverov
Published: (2019-03-01)

Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis
by: Guohong-Liu, et al.
Published: (2019-11-01)

Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis
by: Maryam Mahjoubin-Tehran, et al.
Published: (2021-08-01)

Overexpression of apolipoprotein A-I alleviates endoplasmic reticulum stress in hepatocytes
by: Qing Guo, et al.
Published: (2017-06-01)

Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma
by: Rahul Kumar, et al.
Published: (2020-04-01)

An epidemiological survey of alcoholic liver disease among staff of Yanchang Oilfield
by: LI Qiannan, et al.
Published: (2017-09-01)

Ethnicity matters: A Systematic Review and Meta-Analysis of the Non-Linear Relationship Between Alcohol Consumption and Prevalence and Incidence of Hepatic Steatosis
by: Michael Roerecke, et al.
Published: (2016-06-01)

The beneficial effects of taurine in alleviating fatty liver disease
by: Qi Song, et al.
Published: (2021-02-01)

State of endogenous intoxication and immune-inflammatory response in patients with alcoholic liver cirrhosis associated with non-alcoholic fatty liver disease
by: N.R. Matkovska, et al.
Published: (2019-04-01)

Non-Alcoholic Fatty Liver Disease in Children: Current View on Diagnostics and Treatment (Part I)
by: Yu.M. Stepanov, et al.
Published: (2015-04-01)

FATTY LIVER DISEASE. MODERN PATHOGENETIC APPROACH TO THERAPY
by: V. M. MAKHOV, et al.
Published: (2016-12-01)

The diagnostic conundrum in non-alcoholic fatty liver disease
by: Valerio Rosato, et al.
Published: (2020-10-01)

Cardiovascular Risk in Patients with Non-alcoholic Fatty Liver Disease
by: Hak Soo Kim, et al.
Published: (2017-06-01)

Non-alcoholic fatty liver disease: time for changes
by: T.I. Yefimenko, et al.
Published: (2021-06-01)

Are patients with alcohol-related fatty liver at increased risk of coronary heart disease?
by: Dong Hyun Sinn, et al.
Published: (2014-06-01)

New Potential of Non-Drug Treatment of Non-alcoholic Fatty Liver Disease
by: N.V. Dragomiretska, et al.
Published: (2014-04-01)

Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
by: Francisco Idalsoaga, et al.
Published: (2020-08-01)

Contrasting Effects of Fasting on Liver-Adipose Axis in Alcohol-Associated and Non-alcoholic Fatty Liver
by: Karuna Rasineni, et al.
Published: (2021-03-01)

Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant
by: Stefano Gitto, et al.
Published: (2016-04-01)

Alcohol Drinking Increased the Risk of Advanced Colorectal Adenomas
by: Yoon Kyung Song, et al.
Published: (2015-01-01)

Beneficial effects of Chinese herbs in the treatment of fatty liver diseases
by: Suraphan Panyod, et al.
Published: (2020-05-01)

Personal or family history of metabolic traits predispose to higher hepatotoxic effects of alcohol
by: Ajeet Singh Bhadoria, et al.
Published: (2019-01-01)

Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases
by: Ciniso Sylvester Shabangu, et al.
Published: (2020-05-01)

Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
by: Ma Ai Thanda Han
Published: (2020-09-01)

Improvement of Diagnostic Algorithm in Patients With Alcoholic Fatty Liver Disease by Using Non-invasive Methods of Verification of Liver Steatosis and Fibrosis
by: Svintsitskyy A., et al.
Published: (2016-07-01)

Non-alcoholic fatty liver disease and type 2 diabetes mellitus: issues of the liver fibrosis diagnostics
by: A. V. Anisonyan, et al.
Published: (2020-09-01)

Liver Cirrhosis as the Outcome of Non-Alcoholic Fatty Liver Disease Associated with PNPLA3 Gene RS738409 Polymorphism
by: I. G. Nikitin, et al.
Published: (2020-03-01)

Risk factors and predictors of non-alcoholic fatty liver disease in Taiwan
by: Ying-Chin Lin, et al.
Published: (2011-04-01)

Significant Burden of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Iranian Population: A Cross-Sectional Analysis
by: Behnam Hosseini Ahangar, et al.
Published: (2020-05-01)